1. Funding Update: Current Situation and Future Prospects
September 18, 2012
Andrea Gay, UNF

2. MR Initiative Annual Expenditure, 2001-2012
Total expenditure = $935 million
* Excluding country contributions

3. Measles & Rubella Initiative Annual Donations and Financial Resource Requirements, Projections, Funding Gap * 94 59 11 36 38 44
Excl. country contrib.
* Excludes all country contributions and direct social mobilization funding from partners

4. Measles & Rubella Initiative Financial Resource Requirements, Projections, Funding Gap 2013-201547
Total Funding Gap : US $96 million 32 18 31
Incl. country contrib.
Anticipated Country Contributions
Anticipated GAVI Contribution (Rubella)
Donor Funds Projected/Pledged/Received
Funding Gap (includes PSC)

5. Resource Requirements by Major Category of Activity, 2013-2015
Total Cost : US $739 million

6. MR Initiative Donors,
* Includes ARC/UNF and other partners

7. Where is the Measles & Rubella Initiative Headed?
2012 measles goals: AFRO (pre-elimination) and WPRO (elimination)
2013 potential SEARO elimination goal set, begin MR introduction campaigns with GAVI support
2015 GIVS (95% mortality reduction) and MDG 4 goals; measles goal in EMRO and EURO (elimination); rubella goal in EURO (elimination)
2020 goal in AFRO (elimination)
Expand rubella introduction where appropriate; set goals
Critical Elements for Success
Political leadership
Timely funding (donor and national governments)
Adequate time for planning and social mobilization
Well performing surveillance

8. Measles and rubella elimination goals by WHO Region, March 2012
World Health Organization
18 January, 2019
Measles and rubella elimination goals by WHO Region, March 2012
2015
2012
SEARO RC in Sept 2009 endorsed a resolution to mobilize support towards eliminate measles, 2010 RC meeting adopted the global 2015 measles targets (95% mortality reduction).
Note: EURO changed target to 2015, EMRO is in process of changing target to 2015
2020
Pre-elim.
(98%)
2012
SEAR: 95% Measles Mortality Reduction by 2015
Elimination 2020?
Americas, Europe, E. Mediterranean, W. Pacific, Africa have measles elimination goals
Americas and Europe have rubella elimination goals 8

9. Considerations for Reorganizing Aspects of MR Initiative Operations
Measles eradication investment case (EIC): research, costing options
Strategic funding for regional elimination goals
Strategic support for non-GAVI eligible countries
Increased surveillance costs (including lab, coverage surveys)
Increased communications costs
Increased training costs for SIAs
Type of MR Initiative involvement (ex: T.A.) in GAVI funded MR intro SIAs or GAVI funded measles SIAs in 6 large countries
Outbreak response fund
Routine immunization
Scale up of MCV1
Increase MCV2 introduction
Rubella & CRS (MR)
Follow-up campaigns